Table I.
Characteristic | UPRNN |
---|---|
Age (years) | |
Mean ± SD | 46.75±6.82 |
Gender | |
Male | 32 |
Female | 21 |
BMI | |
Mean ± SD | 23.47±2.67 |
Prescriptive dose of ulcer zone (Gy) | |
Mean ± SD | 70.59±2.36 |
T stage | |
T1 | 0 |
T2 | 2 |
T3 | 36 |
T4 | 15 |
Sites of involvementb | |
1–3 | 24 |
>3 | 29 |
Grades of ulcer | |
Mild | 4 |
Moderate | 27 |
Severe | 22 |
Chemotherapy | |
Neo-CT | 34 |
Concurrent | 18 |
Adjuvant | 12 |
Response of neo-CT | |
SD | 22 |
PR | 12 |
CR | 0 |
Intervala (months) | |
Mean ± SD | 2.92±1.26 |
Outcome of UPRNN | |
Alive | 48 |
Succumbed to mortality | 5 |
The interval from the completion of radiotherapy to the diagnosis of ulcer of post-radiation nasopharyngeal necrosis.
The sites of involvement included the medial pterygoid muscle, lateral pterygoid muscle, parapharyngeal space, musculus longus capitis and the skull base. BMI, body mass index; neo-CT, neoadjuvant chemotherapy; SD, stable disease; PR, partial response; CR, complete response; SD, standard deviation; UPRNN, ulcer of post-radiation nasopharyngeal necrosis.